Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Clin Microbiol ; 47(12): 4144-5, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19794037

RESUMO

The clarithromycin resistance and CagA status of Helicobacter pylori in Thai children were investigated using fecal samples. Of the 284 samples, H. pylori was detected in 120 samples, and the clarithromycin resistance rate was 29.2%. The cagA gene was detected in 59 samples, and only 6.8% of these samples contained the East Asian CagA type.


Assuntos
Antibacterianos/farmacologia , Claritromicina/farmacologia , Farmacorresistência Bacteriana , Fezes/microbiologia , Helicobacter pylori , Antígenos de Bactérias/genética , Proteínas de Bactérias/genética , Criança , Pré-Escolar , Feminino , Helicobacter pylori/classificação , Helicobacter pylori/efeitos dos fármacos , Helicobacter pylori/genética , Helicobacter pylori/isolamento & purificação , Humanos , Lactente , Masculino , Testes de Sensibilidade Microbiana , Prevalência , Tailândia/epidemiologia
2.
Helicobacter ; 14(3): 202-7, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19702850

RESUMO

BACKGROUND: The role of probiotics in the armamentarium remains to be defined. The aims of this study were to investigate whether the long-time administration of Lactobacillus gasseri OLL2716 (LG21) strain can eradicate H. pylori in asymptomatic pre-school children and/or prevent H. pylori infection. METHODS: A total of 440 children, from 5-7 years of age, attending a kindergarten in Thailand were screened by the Helicobacter pylori stool antigen (HpSA) test. Thereafter 132 H. pylori positive and 308 H. pylori negative children were recruited to eradication and randomized prevention arms, respectively. Children in the active and placebo treatment groups received Lactobacillus gasseri OLL2716 (LG21) containing cheese and ordinary cheese, respectively, for 12 months. Eradication was defined as reversion by HpSA at 12 months. Prevention was defined as persistently HpSA negative at 12 months. RESULTS: Eighty-two of 132 H. pylori positive (62%) completed the eradication arm, of which 24 (29.3%) were negative at 12 months according to the HpSA test. In the randomized prevention arm, 123 of 156 (79%) and 99 of 122 (81%) completed active and placebo arms, respectively, of which 4.1% and 8.1%, respectively, were HpSA positive at 12 months based on a per-protocol analysis (p = .21). CONCLUSION: Further trials are needed.


Assuntos
Infecções por Helicobacter/prevenção & controle , Infecções por Helicobacter/terapia , Helicobacter pylori/isolamento & purificação , Lactobacillus/fisiologia , Probióticos/uso terapêutico , Criança , Pré-Escolar , Fezes/microbiologia , Feminino , Humanos , Masculino , Placebos/administração & dosagem , Tailândia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA